Attention Deficit Disorder with Hyperactivity: all 1,547 studies

Page 15 of 16. Open to participants first (254), then studies with results posted, then the rest; newest registration first within each.

• Methylphenidate Study in Young Children With Developmental DisordersCompletedNCT00517504Phase 4
• Pilot Study Examining Effect for Dextroamphetamine to Treat Cocaine Dependence Plus Attention-deficit Hyperactivity Disorder (ADHD)TerminatedNCT00514202Phase 2
• Mazindol in Children With ADHD : Open-label, Efficacy, Safety and Pharmacokinetic Pilot TrialCompletedNCT00508677
• Cognitive Training in Attenuating Attention Deficits/Child Treatment for CancerActive, not recruitingNCT00498719
• Validity of ADHD Subtypes Using Neuropsychological MeasureCompletedNCT00494819
• Time Perception Deficits and Attention-Deficit/Hyperactivity DisorderCompletedNCT00491647
• Chinese Versions of the Swanson, Nolan, and Pelham, Version IV (SNAP-IV) Scale and Strengths Difficulties Questionnaire.CompletedNCT00491361
• Anger Control Training for Youth With Tourette SyndromeCompletedNCT00486551Not applicable
• Evaluation of Continuous Symptom Treatment of ADHDCompletedNCT00486122Phase 4
• Comparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients With ADHDCompletedNCT00486083Phase 3
• Safety and Efficacy of Switching From a Stimulant Medication to Atomoxetine in Children and Adolescents With ADHDCompletedNCT00485875Phase 4
• A Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behaviour Problems in Children With ASDCompletedNCT00485849Phase 4
• Effects of Ritalin on Postural Stability of Hyper Active ChildrenCompletedNCT00485797Not applicable
• Safety Study in Outpatient Japanese Children With ADHDCompletedNCT00485628Phase 2
• Comparison of Atomoxetine Plus Either Comparator or Placebo in Children With ADHD Who Haven't Responded to Stimulant TherapyCompletedNCT00485550Phase 3
• Atomoxetine Hydrochloride Versus Placebo in Taiwanese Children and Adolescents With ADHDCompletedNCT00485459Phase 3
• Guiding Dose Increases in Patients Incompletely Responsive to Usual Doses of AtomoxetineCompletedNCT00485407Phase 3
• Clinical and Pharmacogenetic Study of Attention Deficit With Hyperactivity Disorder (ADHD)CompletedNCT00483106Phase 4
• Efficacy and Effectiveness of Methylphenidate in Swedish Male Prison Inmates With Attention-deficit Hyperactivity Disorder (ADHD)CompletedNCT00482313Phase 3
• Efficacy and Safety of NS2359 in Adults With Attention Deficit Hyperactivity DisorderCompletedNCT00467428Phase 2
• Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHDCompletedNCT00466791Phase 2
• Compliance Survey of ADHD Medication for Optimal Satisfaction (COSMOS)CompletedNCT00460720
• A Study of SPD465 in Young Adult Drivers With Attention-Deficit Hyperactivity Disorder (ADHD) Using Driving SimulatorsWithdrawnNCT00458445Phase 3
• Procedural Learning in Participants With ADHDStatus unknownNCT00446537Early Phase 1
• Safety and Efficacy of MTS Versus Concerta in Pediatric Patients (Aged 6-12 Years) With ADHDCompletedNCT00444574Phase 3
• A Safety and Tolerability Study of ABT-089 in Adults With Attention Deficit-Hyperactivity Disorder (ADHD)CompletedNCT00443391Phase 2
• Methylphenidate for Treating Children With ADHD and Tourette SyndromeCompletedNCT00441649Not applicable
• Dietary Intake and Nutrient Status of Children With ADHDCompletedNCT00434928
• Parent-Provider Intervention for Improving Medication Adherence in Children With Attention Deficit Hyperactivity DisorderWithdrawnNCT00429221Not applicable
• A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedNCT00429091Phase 2
• Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHDCompletedNCT00417794Phase 1
• A Follow-up, Family Study on Attention-deficit Hyperactivity DisorderCompletedNCT00417781
• Neuropsychological Functioning Among Children With Tourret's Disorder and ADHDCompletedNCT00416091
• Preschool Supplement to Clonidine in ADHD (Kiddie-CAT)CompletedNCT00414921Phase 2
• Parent Training to Promote Early Identification and Treatment of Childhood Behavioral DisordersCompletedNCT00402857Phase 3
• Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone.CompletedNCT00399698Phase 3
• PET Scanning of Adults With Attention Deficit Hyperactivity Disorder (ADHD)CompletedNCT00397748
• A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedNCT00391729Phase 2
• Inflammation in Children With Attention-Deficit/Hyperactivity DisorderStatus unknownNCT00391495
• Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Russian Children and Adolescents With Attention-Deficit/Hyperactivity DisorderCompletedNCT00386581Phase 3
• Supplementation of Phosphatidylserine (PS) and n-3 Long Chain Fatty Acids (EPA, DHA) in Children With ADHDCompletedNCT00382616Phase 2
• The COMACS Study: A Comparison of Methylphenidates in an Analog Classroom SettingCompletedNCT00381758Phase 4
• Organizational Skills Training for Children With Attention Deficit Hyperactivity DisorderCompletedNCT00381407Not applicable
• Adverse Effect of Prolonged Methylphenidate Treatment on Cardiac FunctionsStatus unknownNCT00372359
• Virtual Reality a Novel Screening and Treatment Aid in Attention Deficit DisorderCompletedNCT00364702Phase 2
• Treatment of Prisoners With Attention Deficit Hyperactive Disorder in Trondheim PrisonCompletedNCT00356070Not applicable
• Study to Evaluate the Efficacy of Modafinil Treatment in Patients With Attention Deficit Hyperactivity Disorder (ADHD) Who Are Responders to Modafinil TreatmentCompletedNCT00343811Phase 3
• Genetic Measurements in Blood Cells of Children Taking Adderall or MethylphenidateCompletedNCT00341029
• Johnston County ADHD Study: Environmental, Reporductive, and Familial Risk Factors for Attention-Deficit Hyperactivity Disorder (ADHD)CompletedNCT00339729
• Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)CompletedNCT00334880Phase 3
• Effect of Ethanol and Genetic Polymorphisms on Bupropion MetabolismWithdrawnNCT00330434Not applicable
• Oral Status and Prevalence of Dental Trauma in Children Treated With Ritalin Due to Attention-Deficit Hyperactivity Disorder (ADHD)CompletedNCT00328224
• A Safety and Effectiveness Study of Methylphenidate HCl Extended-release Tablets in Adults With Attention Deficit Hyperactivity DisorderCompletedNCT00326391Phase 3
• A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity DisorderCompletedNCT00326300Phase 3
• Methylphenidate for Treating Attention Deficit Hyperactivity Disorder in Children With Both ADHD and EpilepsyCompletedNCT00323947Phase 4
• A Naturalistic Prospective Study of Treatment Effectiveness for Attention-Deficit/Hyperactivity Disorder (ADHD)WithdrawnNCT00323700
• Efficacy of Concerta in Treating ADHD in Mothers of Children With ADHDCompletedNCT00318981Phase 4
• Efficacy, Safety, and Tolerability of Ambien (Zolpidem) in the Treatment of Children Ages 6 to 17 With Attention Deficit Hyperactivity Disorder (ADHD)-Associated InsomniaCompletedNCT00318448Phase 3
• Integrated Parent Training for Treating Depression in Mothers of Children With Attention Deficit Hyperactivity DisorderCompletedNCT00316290Not applicable
• Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHDCompletedNCT00315276Phase 2
• Breathing Meditation With Methylphenidate for the Treatment of Attention Deficit Hyperactivity DisorderStatus unknownNCT00310986Not applicable
• Evaluating Clinical Outcomes of Treatment Effectiveness for Children and Adults With ADHDCompletedNCT00307268
• Aripiprazole Associated With Methylphenidate in Children and Adolescents With Bipolar Disorder and ADHDCompletedNCT00305370Phase 4
• An Effectiveness and Safety Study of CONCERTA* vs. Immediate Release Methylphenidate (IR MPH) in Attention Deficit Hyperactivity Disorder ChildrenCompletedNCT00304681Phase 3
• Naturalistic Substitution of Concerta in Adult Subject With ADHD Receiving Immediate Release MethylphenidateCompletedNCT00302406Phase 4
• An Open Label Phase I/II Study of the Safety and Dopamine Transporter Binding Properties of C-11 Altropane in Normal Human Subjects and in Subjects With ADHDCompletedNCT00302380
• Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity DisorderCompletedNCT00301236Phase 3
• Atomoxetine for Children With Acquired Attentional Disorders Following Completion of Chemotherapy for ALLTerminatedNCT00299234Phase 4
• Effects of L-Theanine in Boys With ADHDCompletedNCT00291070Phase 2
• Home Based Treatment for Drug Use in Early AdolescentsCompletedNCT00280228Phase 2
• Long-term Safety and Effectiveness of OROS Methylphenidate HCl in Children With Attention Deficit Hyperactivity DisorderCompletedNCT00269815Phase 3
• A Multicenter Study Comparing the Efficacy and Safety of OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity DisorderCompletedNCT00269802Phase 3
• A Comparative Effectiveness Study Evaluating OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl), and Placebo for the Treatment of Attention Deficit Hyperactivity Disorder in ChildrenCompletedNCT00269789Phase 3
• An Effectiveness and Safety Study Evaluating OROS Methylphenidate Hydrochloride (HCl), Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity DisorderCompletedNCT00269776Phase 3
• Strongest Families (Formerly Family Help Program): Pediatric Attention Deficit/Hyperactivity DisorderCompletedNCT00267605Phase 2
• Treatment of Patients With Alcoholism and Attention Deficit DisorderCompletedNCT00261872Phase 4
• Placebo-Controlled Comparison of Two Different Brands of Modified-Release Oral Dosage Forms Regarding Safety and Efficacy in Children With Attention Deficit Hyperactivity Disorder (ADHD) Aged 6 - 14CompletedNCT00254878Phase 3
• Effect of Atomoxetine on ADHD-Related Insomnia in Children and AdolescentsStatus unknownNCT00252278Phase 4
• An Effectiveness and Safety Study of CONCERTA® (Methylphenidate Hydrochloride) in the Treatment of Adolescents With Attention Deficit Hyperactivity DisorderCompletedNCT00249353Phase 3
• Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant AbuseCompletedNCT00248092Phase 1/2
• Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse HistoriesCompletedNCT00247572Phase 2
• A Study of the Effectiveness and Safety of Prolonged-release Methylphenidate Hydrochloride in Adult Patients With Attention Deficit/Hyperactivity Disorder.CompletedNCT00246220Phase 3
• CONCERTA (OROS Methylphenidate Hydrochloride) for the Treatment of Attention Deficit Hyperactivity Disorder in AdultsCompletedNCT00246207Phase 3
• Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity DisorderCompletedNCT00228046Phase 4
• Methylphenidate and Driving Ability in Adult Patients With Attention-Deficit Hyperactivity DisorderCompletedNCT00223561Phase 4
• Study of Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder)CompletedNCT00221962Phase 4
• Effectiveness of ATMX in Treating Adolescents With ADHD and SUDCompletedNCT00218322Phase 4
• Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder.CompletedNCT00216918Phase 4
• Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHDCompletedNCT00214981Phase 3
• Safety and Efficacy of SPD465 in Adults With ADHDCompletedNCT00202605Phase 2
• Open-Label Trial of Atomoxetine to Evaluate Academic Outcome in Children Ages 8-11 Years With Attention Deficit/Hyperactivity DisorderCompletedNCT00191880Phase 3
• An Open-Label Study of Atomoxetine in Adolescents With Attention-Deficit/Hyperactivity DisorderCompletedNCT00191737Phase 3
• Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and ODDCompletedNCT00191698Phase 3
• Study of Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/AdolescentsCompletedNCT00191659Phase 3
• Study of Atomoxetine in Children With ADHD to Assess Symptomatic and Functional OutcomesCompletedNCT00191633Phase 4
• Atomoxetine vs Placebo in the Treatment of ADHD in Swedish Children and AdolescentsCompletedNCT00191542Phase 3
• An Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity DisorderCompletedNCT00191516Phase 3
• Atomoxetine Versus Placebo in Children With Attention Deficit/Hyperactivity Disorder (ADHD)CompletedNCT00191295Phase 2/3
• Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHDCompletedNCT00191048Phase 4
• Maintenance of Benefit With Atomoxetine Hydrochloride in Adolescents With ADHDCompletedNCT00191035Phase 4

← Attention Deficit Disorder with Hyperactivity overview